Stocks
Arcturus Therapeutics Holdings (ARCT) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 6.30 | 1.50 | -22.0 | 4.28 | 10.8 | 3.56 | |||
| Changes by years, y/y, % | +199% | -76% | -1 562% | -119% | +153% | +53.4% | |||
Arcturus Therapeutics Holdings. Debt/EBITDA
Arcturus Therapeutics Holdings. Debt/EBITDA, changes, %
Arcturus Therapeutics Holdings (ARCT) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q4 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| Debt/EBITDA | 3.07 | 3.43 | 2.59 | 4.44 | 3.56 | 3.56 | ||
| Changes by years, y/y, % | -118% | -120% | -142% | -129% | -154% | |||
| Changes by quarters, q/q, % | -147% | +12% | -25% | +71% | -20% | |||
